Tag: Treatments
Business & Industry
Daiichi Eyes Commercialization of its Leukemia Med Vanflyta
Daiichi Sankyo is now looking out for new horizons when it comes to its leukemia med Vanflyta, with Genesis Pharma signing to commercialize the drug...
Business & Industry
Nimbus, Lilly Ink Licence Agreement on Treatments in Obesity
Nimbus Therapeutics has announced that it has entered into a multi-year research partnership and a $1.3 billion exclusive license agreement with Eli Lilly in...
Drug Research
UK Plans to Produce Cancer Treatment from Nuclear Waste
Bicycle Therapeutics has entered into a 15-year agreement with the UK Nuclear Decommissioning Authority (NDA) to utilize reprocessed uranium from nuclear reactors for the...
Drug Research
Regeneron Looks to Infusing More Funds into Gene Editing
Regeneron Pharmaceuticals is going ahead and investing more funds into gene editing, as it has announced a collaboration with Tessera Therapeutics in December 2025,...
BioPharma
FDA Looks to Accelerate Biosimilar Drug Development
The FDA has gone on to propose certain new policies in order to accelerate biosimilar drug development and at the same time also lower...
Press Releases
Aptar Digital Health Announces FDA 510(k) Clearance for HeroTracker® Sense, a Connected Add-On Device for MeteredDose Inhalers
Aptar Digital Health, a global leader in digital health solutions enhancing the patient experience, today announced that the U.S. Food and Drug Administration (FDA)...
Business & Industry
Thermo Fisher Scientific to Accelerate Life Science Breakthroughs with OpenAI
Thermo Fisher Scientific Inc., the world leader in serving science, announced plans to further increase the impact of Thermo Fisher’s proven growth strategy through...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read